17 alpha-hydroxylase deficiency screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Mehrian.jafari moved page Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency screening to 17 alpha-hydroxylase deficiency screening) |
(No difference)
| |
Revision as of 16:34, 20 July 2017
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency screening On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency screening |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Prenatal screening for congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency by measuring adrenal steroids in the amniotic fluid and monitoring maternal urine steroid metabolite excretion.
Screening
- Measuring adrenal steroids in the amniotic fluid helps in prenatal screening of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency.[1]
- Monitoring maternal urine steroid metabolite excretion is also used for prenatal screening for congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency
References
- ↑ Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016